Insider · CIK 0001690103
Harel Gadot
Files at MBOT (Microbot Medical Inc.). First filing -, latest -.
In brief
Harel Gadot files SEC Form 4 as CEO, president, chair and director at MBOT (Microbot Medical Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Harel Gadot has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | MBOT Microbot Medical Inc. | AGrant or award Stock Option (Right to Buy)derivative | +480,000 | $0.00 | $0 | 480,000 | Feb 20, 2026 |
| Feb 5, 2025 | MBOT Microbot Medical Inc. | AGrant or award Stock Option (Right to Buy)derivative | +228,000 | $0.00 | $0 | 228,000 | Feb 7, 2025 |
| Feb 26, 2024 | MBOT Microbot Medical Inc. | AGrant or award Stock Option (Right to Buy)derivative | +12,000 | $0.00 | $0 | 12,000 | Feb 7, 2025 |
Questions about Harel Gadot
Answered from the filings on this page, as of the latest one.
Is Harel Gadot buying or selling?
Harel Gadot has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Harel Gadot's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Harel Gadot has 0.
Where does Harel Gadot file Form 4?
Harel Gadot has filed Form 4 at MBOT (Microbot Medical Inc.) as Chairman, President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.